The global digital neuro biomarkers market is projected to surpass USD 5,188.2 million by 2033, with a robust compound annual growth rate (CAGR) of 24.7% from 2023 to 2033. Digital biomarkers, which include behavioral, clinical, or physiological markers, are measurable and analyzable through digital technologies. These biomarkers are derived from data collected via wearable sensors, smartphones, and other digital devices, offering real-time insights into an individual's health and well-being.